No Data
No Data
Cathie Wood's ARK Investment Bought 358.6K Shares of Personalis Today
Tempus AI, Inc (TEM) Expands Partnership With Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma
Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $7
Personalis (PSNL) Gets a Buy From Lake Street
Personalis and Tempus Expand Collaboration to Biopharma
Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 33% Lower
Unlock the Full List